Neucyte Inc.

Mountain View, CA

UEI
X263NRWQNLL6
CAGE
7JNY8
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
319 N Bernardo Ave, Mountain View, CA 94043, USA
Website
neucyte.com
Founded
2015
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $537,000

Contract awards

Grant awards

Similar vendors

About the company

Neucyte Inc. is a minority-owned, for-profit, Asian-Pacific American-owned small business specializing in advanced biomedical research and development, with a focus on innovative microphysiological systems and drug screening technologies. The company is registered in SAM.gov and has been actively receiving federal contracts and grants since 2016, demonstrating expertise in developing cutting-edge laboratory technologies and research platforms primarily for civilian scientific agencies.

Through federal contract awards, Neucyte Inc. has primarily provided specialized laboratory supplies and research development services to civilian agencies. The Environmental Protection Agency's Office of Research and Development has awarded the company purchase orders for SynFire Co-Culture Kits, with contract values ranging from $37,000 to $64,537.50. The National Institutes of Health has also awarded the company a $500,000 firm fixed price contract to develop a miniaturized automated drug screening platform, with the contract designated as a total small business set-aside. These contracts are consistently structured as small business set-asides, leveraging Neucyte's status as a minority-owned business to support federal procurement diversity goals.

Neucyte Inc.'s federal grant awards are predominantly from the National Institute on Aging, focusing on developing advanced microphysiological systems for Alzheimer's disease and related dementia research. The company has received two $500,000 Project Grants under the Aging Research program to develop innovative "mini-brain" assembloid models using human induced pluripotent stem cell technology. These grants aim to create scalable, reproducible brain models that can more effectively recapitulate the in vivo environment for preclinical drug discovery. The research platforms incorporate advanced technologies like nanoluciferase-based assays and microfluidics to enable high-throughput screening of potential therapeutics, with a specific focus on addressing the challenges of translating drug discoveries from animal models to human brain-specific diseases.

Quick answers

Is Neucyte Inc. registered in SAM.gov?

Yes. Neucyte Inc.'s SAM.gov registration is active through July 21, 2027.

What is Neucyte Inc.'s CAGE code?

Neucyte Inc.'s CAGE code is 7JNY8, and its Unique Entity ID (UEI) is X263NRWQNLL6.

How much has Neucyte Inc. received in federal contracts?

Federal contracts obligated $537,000 to Neucyte Inc. in fiscal years 2023 through 2027.

What is Neucyte Inc.'s most recent federal award?

Neucyte Inc.'s most recent federal grant award is Nanoluciferase-based ad/adrd microphysiological systems platform for high-throughput screening (R41AG085831), from National Institute on Aging (NIH), on September 15, 2024.

On GovTribe

See Neucyte Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe